These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays. Kuhn J, Gripp T, Flieder T, Hammerschmidt A, Hendig D, Faust I, Knabbe C, Birschmann I. Clin Chim Acta; 2018 Nov; 486():347-356. PubMed ID: 30114406 [No Abstract] [Full Text] [Related]
5. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma. Lagoutte-Renosi J, Le Poupon J, Girard A, Montange D, Davani S. J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov 15; 1100-1101():43-49. PubMed ID: 30292948 [Abstract] [Full Text] [Related]
6. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolution mass spectrometry. Gous T, Couchman L, Patel JP, Paradzai C, Arya R, Flanagan RJ. Ther Drug Monit; 2014 Oct 15; 36(5):597-605. PubMed ID: 24695356 [Abstract] [Full Text] [Related]
10. UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays. Kuhn J, Gripp T, Flieder T, Dittrich M, Hendig D, Busse J, Knabbe C, Birschmann I. PLoS One; 2015 Oct 15; 10(12):e0145478. PubMed ID: 26699714 [Abstract] [Full Text] [Related]
12. Simultaneous Determination of Dabigatran, Rivaroxaban, and Apixaban in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry. Zhang M, Moore GA, Chin PKL. Ther Drug Monit; 2020 Jun 15; 42(3):473-480. PubMed ID: 32053549 [Abstract] [Full Text] [Related]
14. Development of an UHPLC-UV-Method for Quantification of Direct Oral Anticoagulants: Apixaban, Rivaroxaban, Dabigatran, and its Prodrug Dabigatran Etexilate in Human Serum. Boehr S, Haen E. Ther Drug Monit; 2017 Feb 15; 39(1):66-76. PubMed ID: 27861316 [Abstract] [Full Text] [Related]
15. Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles. Goto E, Horinaka S, Ishimitsu T, Kato T. Drug Metab Pharmacokinet; 2020 Feb 15; 35(1):151-159. PubMed ID: 32007354 [Abstract] [Full Text] [Related]
16. Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs. Mikus G, Foerster KI, Schaumaeker M, Lehmann ML, Burhenne J, Haefeli WE. Clin Pharmacokinet; 2019 Sep 15; 58(9):1155-1163. PubMed ID: 30828771 [Abstract] [Full Text] [Related]
17. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays. Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J. Clin Lab; 2018 Oct 01; 64(10):1611-1621. PubMed ID: 30336535 [Abstract] [Full Text] [Related]